Creating a new path in diagnostics
Location
Basel-Stadt
Industry
Biotechnology
Employees
51-200
Country of origin
South Korea
Noul the New Gold Standard in blood cell diagnostics.
Noul from South Korea works with the Swiss Tropical and Public Health Institute (Swiss TPH) to improve the diagnosis of Malaria, a major cause of death among children in low and middle income countries. The Noul team have developed a portable device that uses image analysis combined with artificial intelligence to diagnose diseases from blood samples. In addition to their work with the DayOne Accelerator, they will be working with the Swiss TPH and the University of Basel to improve their existing AI algorithms.
”The meetings we had so far are extremely beneficial and helpful. Strategically, it pays off to be in Basel and be close to our partner, the Swiss TPH and in traveling distance to our stakeholders in Geneva. So far, the DayOne Accelerator proves to be very effective.
Chang YunFounder
